Skip to main content

Table 4 MVA of CSS

From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy

Parameter p value HR (95% CI)
Age (≥ 50 vs. <  50 years) 0.140 1.791 (0.826–3.883)
Gender (male vs. female) 0.822 1.092 (0.506–2.355)
ECOG (3–4 vs 0–2) 0.591 1.273 (0.527–3.075)
Size (≥ 5 cm vs. <  5 cm) 0.701 0.792 (0.241–2.603)
OP method (non-gross total vs. gross total) 0.627 0.831 (0.393–1.755)
RT field (whole brain vs. small) 0.382 1.449 (0.631–3.325)
Galectin-1 (strong vs. weak) 0.022 2.873 (1.163–7.101)
Galectin-3 (strong vs. weak) 0.993 1.004 (0.426–2.364)
  1. MVA multivariate statistical analysis, CSS cancer-specific survival, ECOG Eastern Cooperative Oncology Group, OP operation, RT radiotherapy